SCI Pharmtech, Inc. (TPE:4119)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.70
+0.40 (0.76%)
Mar 26, 2026, 1:30 PM CST

SCI Pharmtech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,2985,82010,82711,5689,3008,012
Market Cap Growth
-39.22%-46.25%-6.40%24.39%16.07%20.00%
Enterprise Value
6,8506,69411,38812,2189,1716,991
Last Close Price
52.7048.7088.5093.2582.0170.66
PE Ratio
58.5654.2020.2539.2530.12143.85
Forward PE
-29.3429.3429.3439.47108.50
PS Ratio
4.694.337.119.6110.349.27
PB Ratio
1.171.081.982.272.562.41
P/TBV Ratio
1.171.091.992.292.602.46
P/OCF Ratio
28.5926.4212.5853.6231.3628.59
EV/Sales Ratio
5.104.987.4710.1510.198.09
EV/EBITDA Ratio
18.9516.4026.5040.2344.1051.56
EV/EBIT Ratio
63.0743.1257.4376.2277.0994.91
Debt / Equity Ratio
0.120.120.180.200.150.00
Debt / EBITDA Ratio
1.541.542.293.412.600.02
Net Debt / Equity Ratio
0.100.100.050.000.08-0.21
Net Debt / EBITDA Ratio
1.351.350.690.041.35-5.09
Net Debt / FCF Ratio
-1.42-1.42-3.46-0.01-0.321.41
Asset Turnover
0.190.190.220.210.200.20
Inventory Turnover
1.471.471.941.641.511.94
Quick Ratio
0.310.310.972.350.611.39
Current Ratio
1.051.051.643.431.351.87
Return on Equity (ROE)
1.98%1.98%10.11%6.75%8.89%1.68%
Return on Assets (ROA)
1.38%1.38%1.78%1.72%1.63%1.05%
Return on Invested Capital (ROIC)
2.55%2.65%3.01%2.88%2.90%2.35%
Return on Capital Employed (ROCE)
2.70%2.70%3.20%2.60%2.80%2.10%
Earnings Yield
1.70%1.85%4.94%2.55%3.32%0.69%
FCF Yield
-6.19%-6.69%-0.80%-7.03%-9.37%-6.13%
Dividend Yield
2.87%-1.70%1.34%0.27%-
Payout Ratio
166.95%166.95%27.94%8.09%-71.36%
Buyback Yield / Dilution
0.54%0.54%-9.44%-1.87%-0.08%0.49%
Total Shareholder Return
3.41%0.54%-7.74%-0.53%0.19%0.49%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.